Exploring the Benefits of a 3D Patient-specific Alignment in Total Knee Arthroplasty (iKA)

January 19, 2026 updated by: zhijun li, KU Leuven
General Aim: to explore the iKA in TKA related to clinical, biomechanical, and functional outcomes.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

First specific aim: to investigate the kinematics during daily functional movements in individuals with the iKA TKA to those with aMA TKA, as well as the healthy control group.

Second specific aim: to investigate kinetics and muscle activation patterns during functional movements in individuals with the iKA aligned TKA to those with aMA TKA, as well as a healthy control group.

Third specific aim: to investigate the impact of the whole body on functional outcomes following iKA and aMA TKA, in comparison to the healthy control group, and to explore the underlying factors contributing to suboptimal outcomes.

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West
      • Bruges, West, Belgium, 8200
        • KULeuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

were age under 85 years. primary robot-assisted TKA using either iKA or aMA. surgery performed two years before enrollment. independent ambulation without assistive devices; and informed consent.

Exclusion Criteria:

history of lower limb trauma or fracture. neurological disorders (e.g., stroke, Parkinson's disease, multiple sclerosis). systemic musculoskeletal diseases (e.g., rheumatoid arthritis, diabetic neuropathy).

revision arthroplasty. and cognitive impairment affecting study participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: To examine the lower limb kinematic differences during the challenging daily functional movements, s
To examine the lower limb kinematic differences during the challenging daily functional movements, such as the lunge, in individuals who have undergone iKA TKA, compared to those with aMA TKA and healthy controls.
This study compared inverse kinematic alignment (iKA) TKA, which preserves native JLO, with adjusted mechanical alignment (aMA) TKA, which standardizes JLO to 90°, and a healthy control group across eight functional activities.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: 2 years after TKA
Stadiometer; height in millimeters
2 years after TKA
Joint angles
Time Frame: 2 years after surgery
Vicon Nexus 2.12 software (©Vicon Motion Systems Ltd., Oxford, UK); Unit: Degrees
2 years after surgery
Age
Time Frame: 2 years after TKA
year
2 years after TKA
Leg Length
Time Frame: 2 years after TKA
Direct Tape Measure; Leg Length in millimeters
2 years after TKA
Inter-ASIS Dist
Time Frame: 2 years after TKA
Vernier caliper, Inter-ASIS Dist in millimeters
2 years after TKA
Knee Width
Time Frame: 2 years after TKA
Vernier caliper, Knee Width in millimeters
2 years after TKA
Ankle Width
Time Frame: 2 years after TKA
Vernier caliper, Ankle Width in millimeters
2 years after TKA
Elbow Width
Time Frame: 2 years after TKA
Vernier caliper, Elbow Width in millimeters
2 years after TKA
Wrist Width
Time Frame: 2 years after TKA
Vernier caliper, Wrist Width in millimeters
2 years after TKA
Hand Thickness
Time Frame: 2 years after TKA
Vernier caliper, Hand Thickness in millimeters
2 years after TKA
Total Gait Cycle Duration
Time Frame: 2 years after TKA
Vicon Nexus 2.12 software (©Vicon Motion Systems Ltd., Oxford, UK); Unit in second
2 years after TKA
Visual Analog Scale
Time Frame: Pre-TKA, 6 weeks after TKA, 2 years after TKA
Pain Scores
Pre-TKA, 6 weeks after TKA, 2 years after TKA
Oxford Knee Score (OKS)
Time Frame: Pre-TKA; 2 years after TKA
total score ranging from 0 to 48
Pre-TKA; 2 years after TKA
maximum voluntary isometric strength tests of the lower limb
Time Frame: 2 years after TKA
Peak force measured with a hand-held dynamometer (Micro FET 2 Handheld Dynamometer, Hoggan, USA); Unit: Newtons
2 years after TKA
Muscle activity patterns for eight muscles (gluteus medius, rectus femoris, vastus medialis, vastus lateralis, biceps femoris, semitendinosus, tibialis anterior and gastrocnemius medialis)
Time Frame: 2 years after TKA
A 16-channel telemetric wireless surface electromyography (EMG) system (Waveplus®, Cometa, Rome, Italy) operating at 1000 Hz was utilized. Unit: Volt
2 years after TKA

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI
Time Frame: 2 years after TKA
weight and height will be combined to report BMI in kg/m2
2 years after TKA

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2024

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Study Registration Dates

First Submitted

December 15, 2025

First Submitted That Met QC Criteria

January 19, 2026

First Posted (Actual)

January 26, 2026

Study Record Updates

Last Update Posted (Actual)

January 26, 2026

Last Update Submitted That Met QC Criteria

January 19, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • S67874
  • B3222022001251 (Other Identifier: Ethics Committee Research UZ/KU Leuven)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

it is a 15 year study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on TKA Outcomes

Clinical Trials on iKA

Subscribe